Stomach cancer
Miriam O'Callaghan, a renowned Irish TV presenter, has shared her personal struggles with health and the devastating loss of her sister, Anne, who passed away from stomach cancer at the age of 33. The Late Late Show host, 65, recalled the moment she realized something was wrong with
Cancer
Researchers from Osaka, Japan have identified a promising biomarker for gastric cancer, which could potentially aid in predicting the effectiveness of a specific immunotherapy treatment. The study, conducted by the Osaka International Cancer Institute, found that a tumor-infiltrating lymphocyte (TIL) biomarker was predictive of the efficacy of nivolumab monotherapy in
Cancer
A new study has shed light on the key mechanisms driving gastric cancer progression, immune evasion, and treatment resistance. According to the research, glucose metabolism reprogramming plays a pivotal role in promoting tumor progression, immune evasion, and treatment resistance in gastric cancer. The study, conducted by a team of researchers
Cancer research
Researchers from the Catholic University of Korea have conducted a study to identify early immunological predictors of response and prognosis in patients with advanced gastric cancer (GC) treated with nivolumab plus chemotherapy. The study aimed to investigate the dynamic immune profiling of patients with GC and its association with treatment
Cancer
A new study has shed light on the potential impact of commonly used drugs, such as proton pump inhibitors, statins, and metformin, on gastric cancer morbidity in Ukraine. Researchers found that the consumption of these medications, as well as cysteine derivatives, increased by 98.61% between 2014 and 2020. Despite
Cancer research
Researchers at the Sungkyunkwan University School of Medicine in Seoul, South Korea, have conducted a study to comprehensively analyze the tumor immune microenvironment (TIME) in peritoneal metastases of gastric cancer. The study aimed to understand the tumor immune microenvironment in patients with gastric cancer and peritoneal metastasis, which is often
Cancer research
A new study conducted by Seoul National University has identified a potential biomarker for predicting the response of intraperitoneal paclitaxel chemotherapy in patients with gastric cancer peritoneal metastases. The research utilized a clinical trial integrated translational study to analyze biomarkers that can predict patient responses to the chemotherapy treatment. The
Cancer
Investigators at Jiangsu Normal University in Jiangsu, People's Republic of China, have identified a novel "contextual programmed lethality" mechanism targeting the lactylation-ferroptosis axis in gastric cancer, highlighting the potential of the flavonoid breviscapine as a therapeutic strategy against diabetes-aggravated cancers. The research demonstrates that breviscapine inhibits
Cancer research
A recent study published in Frontiers in Immunology has identified serum lactate and pyruvate as non-invasive biomarkers with significant predictive value for immunotherapy efficacy in advanced gastric cancer. The research conducted by a team of scientists at Nanjing Medical University found that patients with decreased serum concentrations of glycolytic metabolites
Cancer
Researchers from the Department of Gastroenterology, Successful Hospital Affiliated to Xiamen University in Fujian, People's Republic of China, have made significant breakthroughs in understanding the molecular mechanisms underlying gastric cancer (GC). By integrating transcriptomics and machine learning, the team identified several ferroptosis-related genes, including Glutamic-Oxaloacetic Transaminase 1 (GOT1)
Cancer research
A groundbreaking study from Harbin Medical University Cancer Hospital in China has made a significant breakthrough in the field of muscular atrophy research. The study's primary aim was to evaluate the prognostic efficacy of the alkaline phosphatase to prealbumin ratio (APR) against eight established hematological biomarkers. The research
Cancer
Research at Chiba University, Japan, has established a connection between Epstein-Barr Virus (EBV) and gastric cancer through the suppression of apoptosis. The study, published in The Journal of Pathology, found that EBV-positive gastric cancers (GCs) exhibit unique carcinogenic pathways that evade apoptosis in the absence of TP53 mutation. The research
